Prospective surveillance for breast cancer-related lymphedema (PROTECT)

References

• Shaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015;65(1):55–81.
   PubMed Web of Science ®Google Scholar
• DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–515.
   PubMed Web of Science ®Google Scholar
• Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology. Lymphology. 2020;53:3–19.
   PubMed Web of Science ®Google Scholar
• Bundred NJ, Barrett E, Todd C, et al. Prevention of lymphoedema after axillary clearance by external compression sleeves PLACE randomised trial results. Effects of high BMI. Cancer Med. 2022;12(5):5506–5516.
   PubMed Web of Science ®Google Scholar
• Shen A, Lu Q, Fu X, et al. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies. Support Care Cancer. 2022;31:18.
   PubMed Web of Science ®Google Scholar
• Dominick SA, Natarajan L, Pierce JP, et al. The psychosocial impact of lymphedema-related distress among breast cancer survivors in the WHEL study. Psychooncology. 2014;23(9):1049–1056.
   PubMed Web of Science ®Google Scholar
• Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002;20(20):4242–4248.
   PubMed Web of Science ®Google Scholar
• Nesvold I-L, Dahl AA, Løkkevik E, et al. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol Stockh Swed. 2008;47:835–842.
   PubMed Web of Science ®Google Scholar
• Tengrup I, Tennvall-Nittby L, Christiansson I, et al. Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol. 2000;39(3):393–397.
   PubMed Web of Science ®Google Scholar
• Gebruers N, Verbelen H, De Vrieze T, et al. Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: a best practice guideline. Eur J Obstet Gynecol Reprod Biol. 2017;216:245–253.
   PubMed Web of Science ®Google Scholar
• Armer JM, Hulett JM, Bernas M, et al. Best practice guidelines in assessment, risk reduction, management, and surveillance for Post-Breast cancer lymphedema. Curr Breast Cancer Rep. 2013;5(2):134–144.
   PubMedGoogle Scholar
• Ostby PL, Armer JM, Dale PS, et al. Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema. J Pers Med. 2014;4(3):424–447.
   PubMedGoogle Scholar
• Postoperativ genoptræning og forebyggelse af senfølger i overkroppen. DBCG National Klinisk Retningslinje (in Danish). 2021. https://www.dmcg.dk/Kliniske-retningslinjer/kliniske-retningslinjer-opdelt-paa-dmcg/brystcancer/postoperativ-genoptraning-og-forebyggelse-af-senfolger-i-overkroppen/
   Google Scholar
• Sundhedsstyrelsen. Danish National Guideline on Late Effects following Surgery for Breast Cancer. [In Danish National klinisk retningslinje for følgevirkninger efter operation for tidlig brystkræft] [Internet]. 2015. https://sundhedsstyrelsen.dk/da/udgivelser/2015/∼/media/498BCA8D56204AA7ACDCF82FE3096C71.ashx
   Google Scholar
• Cancer-Related Lymphedema. Status Report from the Danish Cancer Society [In Danish: en kortlægning af lymfødem i relation til kræft. Statusrapport Kræftens Bekæmpelse]. 2016. www.cancer.dk/dyn/resources/File/file/9/6259/1490952601/lymfoedem-rapport_final_feb-2017.pdf
   Google Scholar
• Rafn BS, Christensen J, Larsen A, et al. Prospective surveillance for breast Cancer-Related arm lymphedema: a systematic review and Meta-Analysis. J Clin Oncol. 2022;40(9):1009–1026.
   PubMed Web of Science ®Google Scholar
• Stout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(8 Suppl):2191–2200.
   PubMed Web of Science ®Google Scholar
• Hayes SC, Johansson K, Stout NL, et al. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer. 2012;118(8 Suppl):2237–2249.
   PubMed Web of Science ®Google Scholar
• Ridner SH, Dietrich MS, Boyages J, et al. A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention. Lymphat Res Biol. 2022;20(6):618–628.
   PubMed Web of Science ®Google Scholar
• Rafn BS, McNeely ML, Camp PG, et al. Self-Measured arm circumference in women With breast cancer Is reliable and valid. Phys Ther. 2019;99(2):240–253.
   PubMed Web of Science ®Google Scholar
• Rafn BS, Singh CA, Midtgaard J, et al. Self-managed surveillance for breast cancer-related upper-body issues: a feasibility and reliability study. Phys Ther. 2020;100(3):468–476.
   Google Scholar
• Ammitzbøll G, Johansen C, Lanng C, et al. Progressive resistance training to prevent arm lymphedema in the first year after breast cancer surgery: results of a randomized controlled trial. Cancer. 2019;125(10):1683–1692.
   PubMed Web of Science ®Google Scholar
• Fu MR, Cleland CM, Guth AA, et al. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology. 2013;46:85–96.
   PubMed Web of Science ®Google Scholar
• Dylke ES, Schembri GP, Bailey DL, et al. Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol. 2016;55(12):1477–1483.
   PubMed Web of Science ®Google Scholar
• Shah C, Vicini FA, Arthur D. Bioimpedance spectroscopy for breast cancer related lymphedema assessment: clinical practice guidelines. Breast J. 2016;22(6):645–650.
   PubMed Web of Science ®Google Scholar
• EUROQOL instruments. 2022. https://euroqol.org/
   Google Scholar
• The DASH Outcome Measure. Institute for Work and Health. 2022 [cited 2022 Oct 11]. Available from: dash.iwh.on.ca
   Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The european organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
   PubMed Web of Science ®Google Scholar